26813111000001106: Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)
\UK product\Virtual medicinal product\Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet\Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)
\UK product\Virtual therapeutic moiety\Rizatriptan\Product containing only rizatriptan in oral dose form (medicinal product form)\Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet\Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)
\UK product\Virtual therapeutic moiety\Rizatriptan\Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet\Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing serotonin receptor agonist (product)\Product containing serotonin 5-hydroxytryptamine-1 receptor agonist\Product containing rizatriptan\Rizatriptan\Product containing only rizatriptan in oral dose form (medicinal product form)\Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet\Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing serotonin receptor agonist (product)\Product containing serotonin 5-hydroxytryptamine-1 receptor agonist\Product containing rizatriptan\Rizatriptan\Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet\Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing serotonin receptor agonist (product)\Product containing serotonin 5-hydroxytryptamine-1 receptor agonist\Product containing rizatriptan\Product containing rizatriptan in oral dose form (medicinal product form)\Product containing only rizatriptan in oral dose form (medicinal product form)\Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet\Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing rizatriptan\Rizatriptan\Product containing only rizatriptan in oral dose form (medicinal product form)\Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet\Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing rizatriptan\Rizatriptan\Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet\Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing rizatriptan\Product containing rizatriptan in oral dose form (medicinal product form)\Product containing only rizatriptan in oral dose form (medicinal product form)\Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet\Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antimigraine agent (product)\Product containing rizatriptan\Rizatriptan\Product containing only rizatriptan in oral dose form (medicinal product form)\Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet\Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antimigraine agent (product)\Product containing rizatriptan\Rizatriptan\Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet\Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antimigraine agent (product)\Product containing rizatriptan\Product containing rizatriptan in oral dose form (medicinal product form)\Product containing only rizatriptan in oral dose form (medicinal product form)\Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet\Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing rizatriptan in oral dose form (medicinal product form)\Product containing only rizatriptan in oral dose form (medicinal product form)\Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet\Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Sep 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

83403201000001113 Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

104310401000001110 Rizatriptan 5mg tablets (Glenmark Pharmaceuticals Europe Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	Has excipient	Aspartame	false	Inferred relationship	Existential restriction modifier
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	Is a	Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	Has active ingredient	Rizatriptan benzoate	false	Inferred relationship	Existential restriction modifier
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	Has specific active ingredient	Rizatriptan benzoate	true	Inferred relationship	Existential restriction modifier
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Rizatriptan	true	Inferred relationship	Existential restriction modifier
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	Has excipient	Excipient not declared	false	Inferred relationship	Existential restriction modifier
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	Has basis of strength substance	Rizatriptan	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd) 3 tablet	Has AMP	True	Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	Inferred relationship	Existential restriction modifier
Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd) 6 tablet	Has AMP	True	Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
83403201000001113	Rizatriptan 5mg tablets (Glenmark Generics (Europe) Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
104310401000001110	Rizatriptan 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module